GraphicGraphicGraphicGraphic Integrin Receptor-mediated Endocytosis of Vitronectin Is Protein Kinase C-dependent (*)

  1. Tracee Scalise Panetti(§),
  2. Sarah A. Wilcox,
  3. Carol Horzempa and
  4. Paula J. McKeown-Longo()
  1. From the Department of Physiology and Cell Biology, Albany Medical College, Albany, New York 12208
  1. To whom correspondence should be addressed:
    Dept. of Physiology and Cell Biology, Albany Medical College, 47 New Scotland Ave., Albany, NY 12208.
    Tel.: 518-262-5666; Fax: 518-262-5669.
  • § Present address: Depts. of Medicine and Biomolecular Chemistry, University of Wisconsin, 1300 University Ave., Madison, WI 53706.

Abstract

Previous studies have demonstrated that the αvβ5 integrin receptor functions in the endocytosis and degradation of matrix-bound vitronectin by human skin fibroblasts (Panetti, T. S., and McKeown-Longo, P. J.(1993) J. Biol. Chem. 268, 11988-11993; Panetti, T. S., and McKeown-Longo, P. J.(1993) J. Biol. Chem. 268, 11492-11495). These earlier studies demonstrated that vitronectin degradation was inhibited by either antibodies to the β5 integrin or exogenous heparin, suggesting that both integrin receptors and cell surface heparan sulfate proteoglycans are involved in the endocytosis and degradation of vitronectin. The present study was done to define intracellular signaling pathways involved in endocytosis of vitronectin and to evaluate the relative contribution of cell surface heparan sulfate proteoglycans and the αvβ5 integrin in the activation of these signaling pathways. The addition of the phorbol ester phorbol 12-myristate 13-acetate (PMA), a protein kinase C activator, to monolayers of human skin fibroblasts, increased vitronectin degradation. Staurosporine and calphostin C, inhibitors of protein kinase C, blocked internalization and subsequent degradation of vitronectin, while KT5720, an inhibitor of protein kinase A, had no effect on the degradation of vitronectin. PMA was also able to reverse the inhibition of vitronectin degradation seen when cells were pretreated with heparinase or incubated with exogenous heparin. In contrast, the inhibitory effect of either RGD peptides or anti-αvβ5 antibodies on vitronectin degradation were not overcome by the addition of PMA. These data suggest that the internalization of vitronectin from the matrix is mediated by the αvβ5 integrin following activation of protein kinase C.

Footnotes

  • * This work was supported by Grant CA-58626 from the National Institutes of Health, Grant AHA-93013270 from the American Heart Association, and Predoctoral Training Grant HL-07194 from the NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    PAI-1

    plasminogen activator inhibitor-type 1

    F-12

    Ham's F-12 nutrient medium

    BSA

    bovine serum albumin

    PBS

    phosphate-buffered saline

    PMA

    phorbol 12-myristate 13-acetate.

    • Received May 12, 1995.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement